Herbert Smith Freehills LLP houses a broad practice which leverages its international network to advise high-profile pharma companies. The group handles numerous patent revocation and infringement actions, in addition to preliminary injunction proceedings. Frédéric Chevallier leads the team, and has vast experience in acting in multi-jurisdictional patent cases.

Legal 500 Editorial commentary

Key clients

  • Sanofi

Work highlights

  • Advising Sanofi in relation to one of its fastest growing products, Aubagio®, for the treatment of multiple sclerosis (teriflunomide). This has involved one patent revocation action initiated by Teva.
  • Advising Sanofi in relation to one of its fastest growing products, Jevtana®, for the treatment of prostate cancer (cabazitaxel). This has involved three preliminary injunction patent proceedings initiated in France against Teva, Accord Healthcare and Ever Pharma, who committed alleged acts of infringement of Sanofi's patent rights, one patent revocation action initiated by Accord Healthcare, and three patent infringement actions started against these entities.

Practice head

The lawyer(s) leading their teams.

Alan Montgomery, Shaun McVicar, Frédéric Chevallier, Laura Orlando